Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. STRATEGIC ALLIANCE AGREEMENTStrategic Alliance Agreement • July 11th, 2007 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
CUMBERLAND PHARMACEUTICALS INC., a corporation organized and existing under the laws of Tennessee, with its principal offices located at 209 Tenth Avenue South, Suite 332, Nashville, Tennessee, 37203 (hereinafter referred to as “CUMBERLAND”)
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. DISTRIBUTION SERVICES AGREEMENTDistribution Services Agreement • July 11th, 2007 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Ohio
This agreement is made as of August 3, 2000, between Cumberland Pharmaceuticals Inc., a Tennessee corporation (“Cumberland”), and CORD Logistics, Inc., an Ohio corporation (“CORD”).
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. Contract Sales and Services Agreement Between Cumberland Pharmaceuticals, Inc. Cardinal Health Contract...Contract Sales and Services Agreement • July 11th, 2007 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
This AGREEMENT (“Agreement”) is dated as of May 16, 2006 by and between Cardinal Health PTS, LLC (“Cardinal Health”) with a place of business at 7000 Cardinal Place, Dublin, Ohio, and Cumberland Pharmaceuticals, Inc. (“Cumberland”), having a principal place of business at 2525 West End, Suite 950, Nashville, Tennessee 37203.
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. FIRST AMENDMENT TO CONTRACT SALES AND SERVICES AGREEMENTContract Sales and Services Agreement • July 11th, 2007 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
This First Amendment to Contract Sales and Services Agreement (the “Amendment”), between Cardinal Health PTS, LLC (“Cardinal Health”) and Cumberland Pharmaceuticals, Inc. (“Cumberland”) is entered into by and between Cardinal Health and Cumberland to modify the terms of the Contract Sales and Services Agreement between the parties dated May 16, 2006 (“Agreement”). All capitalized terms used in this Amendment shall have the meaning ascribed to them in the Agreement.
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. KRISTALOSE AGREEMENT Between CUMBERLAND PHARMACEUTICALS INC. And INALCO BIOCHEMICALS, INC. And INALCO...Kristalose Agreement • July 11th, 2007 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Abbreviations LTL lactulose; LTS lactose; EPI epilactose; GLT galactose; ND carbohydrates different from LTL, LTS, EPI, and GLT.
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. License Agreement between Vanderbilt University and Cumberland Pharmaceuticals Inc.License Agreement • July 11th, 2007 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
THIS AGREEMENT, by and between VANDERBILT UNIVERSITY, a not-for-profit corporation, organized and existing under the laws of the state of Tennessee (“VANDERBILT”), and Cumberland Pharmaceuticals Inc., a Tennessee corporation, having a principal place of business at Nashville, Tennessee (the “LICENSEE”) is effective as of the 28TH day of May , 1999 (the “EFFECTIVE DATE”).
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. MANUFACTURING AND SUPPLY AGREEMENT for N-ACETYLCYSTEINE CUMBERLAND PHARMACEUTICALS INC. and BIONICHE LIFE...Manufacturing Agreement • July 11th, 2007 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • New York
CUMBERLAND PHARMACEUTICALS INC., a corporation organized and existing under the laws of Tennessee, United States, with its principal offices located at 209 Tenth Avenue South, Suite 332, Nashville, Tennessee, 37203 (hereinafter referred to as “CUMBERLAND”)
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. 2525 WEST END OFFICE LEASE AGREEMENT BY AND BETWEEN NASHVILLE HINES DEVELOPMENT, LLC AS LANDLORD AND...Office Lease Agreement • July 11th, 2007 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
THIS LEASE AGREEMENT (“Lease”) is made and entered into on this 10th day of Sept , 2005 (the “Date of Lease”), by and between NASHVILLE HINES DEVELOPMENT, LLC, a limited partnership organized under the laws of the State of Delaware, whose address for purposes hereof is Five Greenway Plaza, Houston, Texas 77046 Attention: F. Russ Nicholson (hereinafter called “Landlord”), and CUMBERLAND PHARMACEUTICALS INC., a Tennessee corporation, whose address for purposes hereof is 2525 West End Avenue, Suite 950, Nashville, TN 37203, Attention: Jean W. Marstiller, (the address of the Leased Premises within the Building) (hereinafter called “Tenant”).
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. FIRST AMENDMENT TO MANUFACTURING AND SUPPLY AGREEMENT FOR N-ACETYLCYSTEINEManufacturing and Supply Agreement • July 11th, 2007 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS FIRST AMENDMENT (the “First Amendment”) to that certain Manufacturing and Supply Agreement for N-Acetylcysteine (the "Agreement”), dated as of January 15, 2002, as modified by that certain Novation Agreement, dated as of January 27, 2006 (to be attached hereto), is entered into by and between CUMBERLAND PHARMACEUTICALS INC., a corporation organized and existing under the laws of Tennessee, United States (“CUMBERLAND”), and BIONICHE TEORANTA, a corporation organized and existing under the laws of Ireland (“BIONICHE”), and is effective as of November 16, 2006. Capitalized terms used but not defined in this First Amendment shall have the meanings that are set forth in the Agreement.
FIRST AMENDMENT TO SECOND AMENDED AND RESTATED LOAN AGREEMENTLoan Agreement • July 11th, 2007 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
THIS FIRST AMENDMENT TO SECOND AMENDED AND RESTATED LOAN AGREEMENT (this “Amendment”), dated December 31, 2006, is made and entered into on the terms and conditions hereinafter set forth, by and between CUMBERLAND PHARMACEUTICALS, INC., a Tennessee corporation (the “Borrower”), and BANK OF AMERICA, N.A., a national banking association (the “Lender”).
CUMBERLAND PHARMACEUTICALS INC. 2007 LONG-TERM INCENTIVE COMPENSATION PLAN NONSTATUTORY STOCK OPTION AGREEMENTNonstatutory Stock Option Agreement • July 11th, 2007 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
This Option Agreement is entered into and effective on ___, by and between Cumberland Pharmaceuticals Inc., a Tennessee corporation (the “Company”), and ___, (the “Participant”).
SECOND AMENDMENT TO CONTRACT SALES AND SERVICE AGREEMENTContract Sales and Service Agreement • July 11th, 2007 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
This Second Amendment to Contract Sales and Service Agreement (the “Second Amendment”) is entered into this 1st day of June, 2007 by and between Inventiv Commercial Services, LLC (“Inventiv”) and Cumberland Pharmaceuticals Inc. (“Cumberland”).
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. SECOND AMENDED AND RESTATED LOAN AGREEMENT April 6, 2006 by and between CUMBERLAND PHARMACEUTICALS, INC.,...Loan Agreement • July 11th, 2007 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
THIS SECOND AMENDED AND RESTATED LOAN AGREEMENT (the “Agreement”) dated as of April 6, 2006, is between BANK OF AMERICA, N.A., a national banking association (the “Bank”) and CUMBERLAND PHARMACEUTICALS, INC., a Tennessee corporation (the “Borrower”).
CUMBERLAND PHARMACEUTICALS INC. 2007 DIRECTORS’ INCENTIVE PLAN NONSTATUTORY STOCK OPTION AGREEMENTNonstatutory Stock Option Agreement • July 11th, 2007 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
This Option Agreement is entered into and effective on ___, by and between Cumberland Pharmaceuticals Inc., a Tennessee corporation (the “Company”), and ___, (the “Participant”).
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. SUBLEASE AGREEMENTSublease Agreement • July 11th, 2007 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
THIS LEASE AGREEMENT (“Lease”) is made and entered into on this 24th day of July, 2000, by and between NASHVILLE HINES DEVELOPMENT, LLC, a limited partnership organized under the laws of the State of Delaware, whose address for purposes hereof is 2800 Post Oak Boulevard, Houston, Texas 77056-6190 Attention: Profit Center Office/Central Division (hereinafter called “Landlord”), and ROBERT W. BAIRD & CO. INCORPORATED, a corporation organized under the laws of the State of Wisconsin, whose address for purposes hereof is 777 East Wisconsin Avenue, Milwaukee, Wisconsin 53202, Attention: D. Michael Shaefer, First Vice President and Manager of Real Estate and Facilities, prior to the commencement of the term of this Lease, and thereafter shall be 2525 West End Avenue, Suite 1000, Nashville, Tennessee 37203 (the address of the leased premises within the Building) (hereinafter called “Tenant”).
Addendum to Sublease Agreement dated December 14, 2006 Between Baird and CPISublease Agreement • July 11th, 2007 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
THIS CONSENT TO ADDENDUM TO SUBLEASE AGREEMENT (this “Amended Consent”) is entered into to be effective as of the Effective Date by and among Lessor, Lessee and Sublessee.
CUMBERLAND PHARMACEUTICALS INC. 2007 LONG-TERM INCENTIVE COMPENSATION PLAN INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • July 11th, 2007 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
This Option Agreement is entered into and effective on ___, by and between Cumberland Pharmaceuticals Inc., a Tennessee corporation (the “Company”), and ___, (the “Participant”).
